Skip to main content
profile image
Selected Works of John M. Pagel, MD, PhD
Article
Multivariate Analysis of Response and Survival After Treatment with Clofarabine, Cytarabine and G-CSF Priming (GCLAC) In Relapsed/Refractory Acute Myeloid Leukemia (AML): Comparison with Prior Experience Using Fludarabine and Cytarabine Combination Regimens.
Blood (2010)
  • Pamela S. Becker, University of Washington
  • Hagop Kantarjian, University of Texas MD Anderson Cancer Center
  • Frederick R. Appelbaum, Fred Hutchinson Cancer Research Center
  • Stephen H. Petersdorf, Fred Hutchinson Cancer Research Center
  • Barry Storer, Fred Hutchinson Cancer Research Center
  • Sherry A. Pierce, University of Texas MD Anderson Cancer Center
  • Jianqin Shan, University of Texas MD Anderson Cancer Center
  • Paul C. Hendrie, University of Washington
  • John M. Pagel, Fred Hutchinson Cancer Research Center
  • Andrei Shustov, University of Washington
  • Derek L. Stirewalt, Fred Hutchinson Cancer Research Center
  • Stefan Faderl, University of Texas MD Anderson Cancer Center
  • Elizabeth Harrington, Fred Hutchinson Cancer Research Center
  • Elihu H. Estey, Fred Hutchinson Cancer Research Center
Link
Disciplines
Publication Date
November 19, 2010
Citation Information
Pamela S. Becker, Hagop Kantarjian, Frederick R. Appelbaum, Stephen H. Petersdorf, et al.. "Multivariate Analysis of Response and Survival After Treatment with Clofarabine, Cytarabine and G-CSF Priming (GCLAC) In Relapsed/Refractory Acute Myeloid Leukemia (AML): Comparison with Prior Experience Using Fludarabine and Cytarabine Combination Regimens." Blood Vol. 116 Iss. 21 (2010) p. 1065 - 1065
Available at: http://works.bepress.com/john-pagel/193/